OptimizeRx Corp (OPRX)
14.64
+0.14
(+0.97%)
USD |
NASDAQ |
Mar 31, 16:00
14.65
+0.01
(+0.07%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 250.35M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -61.18% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.169 |
| Price to Book Value | 1.985 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 87.20% |
News
Headline
Wire
Time (ET)
Globe Newswire
03/29 09:20
Yahoo
03/12 08:40
Analysts Have Lowered Expectations For OptimizeRx Corporation (NASDAQ:OPRX) After Its Latest Results
Yahoo
03/11 07:13
MT Newswires
03/09 11:15
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/04/2023* | 16:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 05/04/2023* | -- | Results | Q1 2023 | -- | -0.07 | -- | |
| 03/08/2023 | 16:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 03/08/2023 | -- | Results | Q4 2022 | 0.25 | 0.24 | 3.55% | |
| 11/08/2022 | 16:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 11/08/2022 | -- | Results | Q3 2022 | 0.07 | 0.04 | 88.48% | |
| 08/09/2022 | 16:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 08/09/2022 | -- | Results | Q2 2022 | 0.04 | 0.09 | -55.56% |
*Estimated Date/Time
Earnings
Profile
| OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
| URL | https://www.optimizerx.com |
| Investor Relations URL | https://investors.optimizerx.com/ |
| HQ State/Province | Michigan |
| Sector | Healthcare |
| Industry | Health Information Services |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | May. 04, 2023 (est.) |
| Last Earnings Release | Mar. 08, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0.00% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 31, 2023.
Fundamentals
| Revenue (TTM) | 62.45M |
| Total Expenses (TTM) | 74.74M |
| Net Income (TTM) | -11.44M |
| Total Assets (Quarterly) | 134.65M |
| Total Liabilities (Quarterly) | 8.540M |
| Shareholders Equity (Quarterly) | 126.11M |
| Cash from Operations (TTM) | 10.65M |
| Cash from Investing (TTM) | -58.18M |
| Cash from Financing (TTM) | -18.95M |
Ratings
Profile
| OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
| URL | https://www.optimizerx.com |
| Investor Relations URL | https://investors.optimizerx.com/ |
| HQ State/Province | Michigan |
| Sector | Healthcare |
| Industry | Health Information Services |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | May. 04, 2023 (est.) |
| Last Earnings Release | Mar. 08, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| OPRX Tweets |